InMed Pharmaceuticals Inc.
Extracted from this filing and checked against the source text.
InMed Pharmaceuticals Inc. shareholders approved Appointment of Independent Registered Public Accounting Firm at the 2023-12-19 meeting.
Proposal No. 2—Appointment of Independent Registered Public Accounting Firm The Corporation’s shareholders voted to approve the appointment of Marcum LLP as the independent registered public accounting firm of the Corporation until the 2024 Annual General Meeting of Shareholders or until a successor is named. Votes For % Votes For Vote Against % Votes Against Abstain Broker Non- Votes 1,169,259 90.45% 0 0% 123,387 0View on SEC.gov
InMed Pharmaceuticals Inc. shareholders approved Election of Directors at the 2023-12-19 meeting.
Proposal No. 1—Election of Directors The Corporation’s shareholders voted to elect the following persons to the board of directors of the Corporation, each to serve until the 2024 Annual General Meeting of Shareholders: Nominee Votes For % Votes For Votes Withheld % Votes Withheld Broker Non-Votes Eric A. Adams 160,711 76.09% 50,513 23.91% 1,081,422 Andrew Hull 141,398 66.94% 69,826 33.06% 1,081,422 Janet Grove 141,882 67.17% 69,342 32.83% 1,081,422 Bryan Baldasare 145,659 68.96% 65,565 31.04% 1,081,422 Nicole Lemerond 145,865 69.06% 65,359 30.94% 1,081,422View on SEC.gov
352 shareholder votes filed in the last 30 days. Browse all shareholder votes →
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.